Therapie der Varizenblutung

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 13, 1996, Pages 416-423

  Gerbes, A L ^a   Fischer, G ^a   Holl, J ^a   Paumgartner, G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; ISOSORBIDE 5 NITRATE; MOLSIDOMINE; OCTREOTIDE; POLIDOCANOL; PROPRANOLOL; SCLEROSING AGENT; SOMATOSTATIN; SPIRONOLACTONE; TERLIPRESSIN; VASOPRESSIN;

CLINICAL FEATURE; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; HUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; REVIEW;

ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS;

EID: 0029985639     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043021     Document Type: Article

References (81)

1. Akriviadis, E., J. Korula, S. Gupta, Y. Ko, S. Yamada: Frequent endoscopic variceal sclerotherapy increases risk of complications. Dig. Dis. Sci. 34 (1989), 1068-1074.
2. Angelico, M., L. Carli, C. Piat, S. Gentile, V. Rinald, E. Bologna, L. Capocaccia: Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 104 (1993), 1460-1465.
3. Bertoni, G., R. Sassatelli, G. Fornaciari, R. Briglia, P. Tansini, A. Grisendi, G. Pedretti, M. Beltrami, R. Conigliaro, D. Pacchione, G. Bedogni: Oral isorbide-5-mononitrate reduces the rebleeding rate during the course of injection sclerotherapy for esophageal varices. Scand. J. Gastroenterol. 29 (1994), 363-370.
4. 3a Besson, I., P. Ingraud, B. Person, D. Boutroux, D. Heresbach, P. Bernard et al.: Sclerotherapy with or without octreotide for acute variceal bleeding. New Engl. J. Med. 333 (1995), 555-560.
5. Bosch, J., J. C. Garcia-Pagan, F. Feu: New approaches in the pharmacological treatment of portal hypertension. J. Hepatol. 17, Suppl. 2 (1993), 41-45.
6. Burroughs, A. K.: Surgery and sclerotherapy for treatment of portal hypertension and oesophageal varices. Drugs 37, Suppl. 2 (1989), 25-29.
7. Burroughs, A. K., G. Hamilton, A. Phillips, G. Mezzanotte, N. McIntyre, K. E. F. Hobbs: A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. New Engl. J. Med. 321 (1989), 857-862.
8. Burroughs, A. K., P. A. McCormick: Variceal bleeding. Acute and long-term management. Baillière's clin. Gastroenterol. 3 (1989), 131-163.
9. Burroughs, A. K., P. A. McCormick: Prevention of variceal rebleeding. Gastroenterol. Clin. N. Amer. 21 (1992), 119-147.
10. Burroughs, A. K.: Acute management of bleeding esophageal varices. Drugs 44, Suppl. 2 (1992), 14-23.
11. Burroughs, A. K.: The natural history of varices. J. Hepatol. 17, Suppl. 2 (1993), S10-S13.
12. Bornman, P. C., J. E. J. Krige, J. Terblanche: Management of oesophageal varices. Lancet 343 (1994), 1079-1084.
13. Chojkier, M., H. O. Conn: Esophageal tamponade in the treatment of bleeding varices. Dig. Dis. Sci. 25 (1980), 267-272.
14. D'Amico, G., M. Traina, G. Vizzini, F. Tine, F. Politi, L. Montalbano, A. Luca, L. Pasta, L. Pagliaro, A. Morabito: Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. J. Hepatol. 20 (1994), 206-212.
15. 13a D'Amico, G., L. Pagliaro, J. Bosch: The treatment of portal hypertension. A meta-analytic review. Hepatology 22 (1995), 332-354.
16. DeFranchis, R., J. P. Pascal, E. Ancona, A. K. Burroughs, M. Henderson, W. Fleig, R. Groszmann, J. Bosch, T. Sauerbruch, C. Soederlund, D. Lebrec, T. I. A. Soerensen, L. Pagliaro: Definition, methodology and therapeutic strategies in portal hypertension. J. Hepatol. 15 (1992), 256-261.
17. Fleig, W. E., E. F. Stange, W. Schönborn, D. Wördehoff, G. Preclik, R. Nuber, K. Rainer: Final analysis of a randomized trial of propranolol vs. sclerotherapy for the prevention of recurrent variceal hemorrhage in cirrhosis. Hepatology 8 (1988), 1220.
18. Freedman, A. M., A. J. Sanyal, J. Tisnado, M. L. Shiffman, V. A. Luketic, R. A. Fisher, M. P. Posner: Results with percutaneous transjugular intrahepatic portosystemic stentshunts for control of variceal hemorrhage in patients awaiting liver transplantation. Transplant. Proc. 25 (1993), 1087-1089.
19. García Pagan, J. C., F. Feu, J. Bosch, J. Rodés: Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. Ann. intern. Med. 11 (1991), 230-238.
20. García Pagan, J. C., J. M. Salmerón, F. Feu, A. Luca, P. Ginés, P. Pizcueta, J. Claria, C. Piera, V. Arroyo, J. Bosch, J. Rodés: Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology 19 (1994), 1095-1099.
21. Gerbes, A. L., J. Remien, D. Jüngst, T. Sauerbruch, G. Paumgartner: Evidence for downregulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1986/I, 1409-1411.
22. Gerbes, A. L., G. Fischer, J. Holl, M. Reiser, G. Paumgartner: Diagnostik der portalen Hypertonie. Dtsch. Med. Wschr. 121 (1996), 210-216.
23. Gerbes, A. L.: Portale Hypertension. In Henne-Bruns, D., M. Dürig, B. Kremer (Hrsg.): Lehrbuch Chirurgie. Duale Reihe (Hippokrates: Stuttgart, im Druck).
24. Gimson, A. E. S., J. K. Ramage, M. Z. Panos, K. Hayllar, P. M. Harrison, R. Williams, D. Westaby: Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 342 (1993), 391-394.
25. 22a Gülberg, V., J. Holl, T. Waggershauser, M. Reiser, G. Paumgartner, A. L. Gerbes: TIPS in der Behandlung der therapierefraktären akuten Varizenblutung bei portaler Hypertension. Z. Gastroenterol. 33 (1996), 101.
26. Hashizume, M., M. Ohta, K. Ueno, K. Tanoue, S. Kitano, K. Sugimachi: Endoscopic ligation of esophageal varices compared with injection sclerotherapy. A prospective randomized trial. Gastrointest. Endosc. 39 (1993), 123-126.
27. Hausegger, K. A., G. E. Klein, F. Flückiger, M. E. Sternthal, R. Wilding, R. Stauber: Klinische Erfahrung mit dem transjugulären intrahepatischen portokavalen Shunt. Fortschr. Röntgenstr. 159 (1993), 229-235.
28. Häring, R., T. Karavias, C. T. Germer: Die portokavale Anastomose als Notoperation bei massiver Ösophagusvarizenblutung. In Paquet, K. J., J. Schölmerich (Hrsg.): Pfortaderhochdruck (Karger: Freiburg 1994), 331-346.
29. Hayes, P. C., J. M. Davis, J. A. Lewis, I. A. D. Bouchier: Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 336 (1990), 153-156.
30. Henderson, J. M.: Portal hypertension and shunt surgery. Advanc. Surg. 26 (1993), 233-257.
31. Henriksen, J., H. Ring-Larsen: Renal effects of drugs used in the treatment of portal hypertension. Hepatology 18 (1993), 688-695.
32. Hirner, A., C. E. Zöckler: Operative Therapie - Historischer Abriß und heutiger Stand. In Paquet, K. J., J. Schölmerich (Hrsg.): Pfortaderhochdruck (Karger: Freiburg 1994), 432-445.
33. Holstege, A.: Medikamentöse Therapie der oberen gastrointestinalen Blutung bei portaler Hypertonie. Dtsch. med. Wschr. 119 (1994), 917-922.
34. Hüppe, D., D. Jäger, A. Tromm, S. Tunn, J. Barmeyer, B. May: Einfluß von Molsidomin auf die portale und kardiale Hämodynamik bei Leberzirrhose. Dtsch. med. Wschr. 116 (1991), 841-845.
35. Infante-Rivard, C., S. Esnaola, J.-P. Villeneuve: Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding. A meta-analysis. Gastroenterology 96 (1989), 1087-1092.
36. Ink, O., T. Martin, T. Poynard, M. Reville, M.-L. Anciaux, C. Lenoir, J. L. Marill, H. Labadie, C. Masliah, D. Perrin, J. C. Chaput, D. Vetter, C. Eugene, L. Lebodic, H. Licht, J. P. Etienne: Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter randomized trial. Hepatology 16 (1992), 912-919.
37. Jenkins, S. A., R. Shields, N. Jaser, S. Ellenbogen, C. Makin, E. Naylor, M. Newstead, J. N. Baxter: The management of gastrointestinal haemorrhage by somatostatin after apparently successful endoscopic injection sclerotherapy for bleeding oesophageal varices. J. Hepatol. 12 (1991), 296-301.
38. Jenkins, S. A.: Somatostatin in acute bleeding oesophageal varices. Drugs 44, Suppl. 2 (1992), 36-55.
39. Johnson, P. A., D. R. Campbell, C. W. Antonson, A. P. Weston, F. N. Shuler, R. D. Lozoff: Complications associated with endoscopic band ligation of esophageal varices. Gastrointest. Endosc. 39 (1993), 181-185.
40. Kleber, G., H. Ansari, T. Sauerbruch: Prophylaxis of first variceal bleeding. Baillière's clin. Gastroenterol. 6 (1992), 563-580.
41. Klein, C. P.: Spironolacton in der Behandlung der portalen Hypertonie bei Leberzirrhose. Ein neues Wirkungsprinzip? Dtsch. med. Wschr. 110 (1985), 1774-1776.
42. LaBerge, J. M., E. J. Ring, R. L. Gordon, J. R. Lake, M. M. Doherty, K. A. Somberg, J. P. Roberts, N. L. Ascher: Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis. Results in 100 patients. Radiology 187 (1993), 413-420.
43. Laine, L., M. Hussein, H. M. El-Newihi, B. Migikovsky, R. Sloane, F. Garcia: Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann. intern. Med. 119 (1993), 1-7.
44. 40a Laine, L., D. Cook: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann. intern. Med. 123 (1995), 280-287.
45. 40b Lo, G., K. Lai, J. Cheng, J. Hwu, C. Chang, S. Chen, H. Chiang: A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 22 (1995), 466-471.
46. Martin, M., A. B. Zajko, P. D. Orons, G. Dodel, H. Wright, J. Colangelo, R. Tartar: Transjugular intrahepatic portosystemic stent in the management of variceal bleeding. Indications and clinical results. Surgery 114 (1993), 719-727.
47. Mazzaferro, V., S. Todo, A. G. Tzakis, A. C. Stieber, L. Makowka, T. E. Starzl: Liver transplantation in patients with previous porto-systemic shunt. Amer. J. Surg. 160 (1990), 111-116.
48. McCormick, P. A., G. L. Kaye, L. Greenslade, F. Cardin, K. E. F. Hobbs, N. McIntyre, A. K. Burroughs: Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy. Hepatology 15 (1992), 403-406.
49. Morillas, R. M., R. Planas, E. Cabré, A. Galán, J. C. Quer, F. Feu, J. C. García Pagán, J. Bosch, M. A. Gassull: Propranolol plus Isosorbide-5-mononitrate for portal hypertension in cirrhosis. Long-term hemodynamic and renal effects. Hepatology 20 (1994), 1502-1508.
50. Neuhaus, P., H. Keck, H. P. Lemmens, O. Guckelberger: Surgical treatment of portal hypertension. In Hahn, E. G., J. Schölmerich (Ed.): Portal Hypertension. Falk Symposium No. 79 (Kluwer: Dordrecht 1995), 335-343.
51. Pagliaro, L., A. K. Burroughs, T. I. A. Sorensen, D. Lebrec, A. Morabito, G. D'Amico, F. Tine: Therapeutic controversies and randomised controlled trials (RCTs). Prevention of bleeding and rebleeding in cirrhosis. Gastroenterol. Int. 2 (1989), 71-84.
52. Pagliaro, L., A. K. Burroughs, T. I. A. Sorensen, D. Lebrec, A. Morabito, G. D'Amico, F. Tine: Beta-blockers for preventing variceal bleeding. Lancet 336 (1990), 1001-1002.
53. Pagliaro, L., G. D'Amico, T. I. A. Sörensen, D. Lebrec, A. K. Burroughs, A. Morabito, F. Tine, F. Politi, M. Traina: Prevention of first bleeding in cirrhosis. Ann. intern. Med. 117 (1992), 59-70.
54. Paquet, K. J., J. Schölmerich (Hrsg.): Pfortaderhochdruck (Karger: Freiburg 1994).
55. Reichen, J., D. Lebrec: The effect of drugs on the portal circulation. J. Hepatol. 5 (1987), 235-240.
56. Richter, G. M., T. Roeren, M. Brado, G. Nöldge, G. W. Kauffmann: Langzeitergebnisse nach TIPSS mit dem Palmaz-Stent. Radiologe 34 (1994), 178-182.
57. Rigau, J., J. Bosch, J. M. Bordas, M. Navasa, R. Mastai, D. Kravetz, J. Bruix, F. Feu, J. Rodes: Endoscopic measurement of variceal pressure in cirrhosis. Correlation with portal pressure and variceal hemorrhage. Gastroenterology 96 (1989), 873-880.
58. Robertz-Vaupel, G. M., T. Sauerbruch: Einsatz der Sklerosierungstherapie bei Patienten mit Ösophagusvarizen. Richtlinien der DGVS. Standards in Gastroenterology. Z. Gastroenterol. 31 (1993). 221-223.
59. Rössle, M., K. Haag, A. Ochs, M. Sellinger, G. Nöldge, J. M. Perarnau, E. Berger, U. Blum, A. Gabelmann, K. Hauenstein, M. Langer, W. Gerok: The transjugularintrahepatic portosystemic stent-shunt proce-dure for variceal bleeding. New Engl. J. Med. 330 (1994), 165-171.
60. Rössle, M., K. Haag, A. Ochs, M. Sellinger, K. H. Hauenstein, M. Langer, W. Gerok: Transjugulärer intrahepatischer portosystemischer Stent-Shunt. Dtsch. med. Wschr. 119 (1994), 31-35.
61. 55a Sackmann, M., A. L. Gerbes: Application of a multiple band ligator in active variceal bleeding. Endoscopy, in press.
62. Sanyal, A. J., M. W. Schubert: Endoscopic ligation versus sclerotherapy. Is it time to jump on the bandwagon? Gastroenterology 105 (1993), 1915-1916.
63. Sarin, S. K., R. Nanda, G. Sachdev, S. Chari, B. S. Anand, S. L. Broor: Intravariceal versus paravariceal sclerotherapy. A prospective, controlled, randomised trial. Gut 28 (1987), 657-662.
64. Sarin, S. K., D. Lahoti: Management of gastric varices. Baillière's clin. Gastroenterol. 6 (1992), 527-548.
65. Sauerbruch, T., M. Weinzierl, H. Ansari, G. Paumgartner: Injection sclerotherapy of oesophageal variceal haemorrhage. A prospective long-term follow-up study. Endoscopy 19 (1987), 181-184.
66. Sauerbruch, T., R. Wotzka, W. Köpeke, M. Härlin, W. Heldwein, E. Bayerdörfer, R. Sander, H. Ansari, I. Starz, G. Paumgartner: Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. New Engl. J. Med. 319 (1988), 8-15.
67. Sauerbruch, T.: Therapie und Prophylaxe der Ösophagusvarizenblutung. Dtsch. med. Wschr. 115 (1990), 940-943.
68. Sauerbruch, T., G. Fischer, H. Ansari: Variceal injection sclerotherapy. Baillière's clin. Gastroenterol. 5 (1991), 131-153.
69. Sauerbruch, T.: Prophylaxis of first variceal bleeding. Where does the truth lie? Endoscopy 26 (1994), 748-749.
70. Sauerbruch, T., G. Kleber, A. L. Gerbes, G. Paumgartner: Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis. Klin. Wschr. 64 (1986), 1267-1275.
71. Shields, R., S. A. Jenkins, J. N. Baxter, A. N. Kingsnorth, S. Ellenbogen, C. A. Makin, I. Gilmore, A. I. Morris, D. Ashby, C. R. West: A prospective randomised trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J. Hepatol. 16 (1992), 128-137.
72. Simpson, K. J., N. Chalmers, D. N. Redhat, D. C. Finlayson, I. A. D. Bouchier, P. C. Hayes: Transjugular intrahepatic portosystemic stent shunting for control of acute and recurrent upper gastrointestinal hemorrhage related to portal hypertension. Gut 34 (1993), 968-973.
73. Snady, H., A. S. Rosman, M. A. Korsten: Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices. Gastrointest. Endosc. 35 (1989), 377-380.
74. Stiegmann, G. V., J. S. Goff, P. A. Michaletz-Onody, J. Korula, D. Lieberman, Z. A. Saeed, R. M. Reveille, J. H. Sun, S. R. Lowenstein: Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. New Engl. J. Med. 326 (1992), 1527-1532.
75. Sung, J. J. Y., S. C. S. Chung, C. W. Lai, F. K. L. Chan, J. W. C. Leung, M. Y. Yung, C. Kassianides, A. K. C. Li: Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 342 (1993), 637-641.
76. Tamura, S., H. Shiozaki, K. Kobayashi, H. Yano, H. Tahara, M. Miyata, T. Mori: Prospective randomized study on the effect of ranitidine against injection ulcer after endoscopic injection sclerotherapy for esophageal varices. Amer. J. Gastroenterol. 86 (1991), 477-480.
77. Terblanche, J., P. C. Bornman, D. Kahn, M. A. T. Jonker, J. A. H. Campbell, J. Wright, R. Kirsch: Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. Lancet 1983/II, 1328-1332.
78. Theilmann, L., P. Sauer: Transjugulärer intrahepatischer portosystemischer Stentshunt (TIPSS). Radiologe 34 (1994), 174-177.
79. Vorobioff, J., E. Picabea, M. Gamen, R. Villavicencio, J. Bordato, F. Bessone, H. Tanno: Propranolol compared with propranolol plus isosorbide dinitrate in portal hypertensive patients. Long-term hemodynamic administration and renal effects. Hepatology 18 (1993), 477-484.
80. Westaby, D., W. Melia, J. Hegarty, A. E. S. Gimson, A. J. Stellon, R. Williams: Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 6 (1986), 673-675.
81. Young, M. F., R. A. Sanowski, R. Rasche: Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest. Endose. 39 (1993), 119-122.